We are looking for a highly motivated PhD student to join the team of Dr. Sebastian Scheich at the Department of Hematology and Oncology at the Goethe University Hospital Frankfurt. The position is limited to a period of 3 years.
The Department offers the full spectrum of blood and cancer diagnostics and therapy. The Emmy-Noether research group of Dr. Sebastian Scheich is part of the Frankfurt Cancer Institute (FCI ) and focuses on aggressive lymphoma biology and signaling. The lab is furthermore funded by grants from philantropy and several governmental organizations (BMFTR DFG) and is embedded in a vibrant research environment within the FCI and maintains lively international collaborations. We apply cutting-edge technologies including genome-wide CRISPR/Cas9 screens quantitative functional proteomics and super resolution microscopy (dSTORM single molecule tracking SIM) to dissect oncogenic signaling pathways study therapy resistance mechanisms and to find novel therapeutic vulnerabilities.
Your Role:
The current research projects are based on a recent publication identifiying N-linked glycosylation as a therapeutic target for the treatment of aggressive lymphomas (Scheich et al. Cancer Disc May 4:CD; Phelan and Scheich et al. Cancer Cell. 2024 Feb 12;42(2):238-252.e9).
Contact: Dr. Sebastian Scheich
Phone: 0(Ms. Platzer Business Office)
Email:
Application Deadline: 25.02.2026
We welcome applications from candidates of all genders. Women are currently underrepresented in these positions at Universitätsmedizin Frankfurt. Therefore applications from women are especially encouraged. Applicants with severe disabilities will be given preferential consideration in cases of equal personal and professional qualifications.
PhD Position in Lymphoma Research • Frankfurt am Main, Hesse, Germany